After delay, ISCO’s trial of Parkinson’s stem cell therapy gets underway again – FierceBiotech
FierceBiotech |
After delay, ISCO's trial of Parkinson's stem cell therapy gets underway again
FierceBiotech A second patient has now been treated in the first trial of a stem cell therapy for Parkinson's disease developed by Californian biotech International Stem Cell Corporation (ISCO). The treatment involves transplants of millions of stem cells delivered … |
